Literature DB >> 28289716

Muscular dystrophy in PTFR/cavin-1 null mice.

Shi-Ying Ding1, Libin Liu1, Paul F Pilch1,2.   

Abstract

ice and humans lacking the caveolae component polymerase I transcription release factor (PTRF, also known as cavin-1) exhibit lipo- and muscular dystrophy. Here we describe the molecular features underlying the muscle phenotype for PTRF/cavin-1 null mice. These animals had a decreased ability to exercise, and exhibited muscle hypertrophy with increased muscle fiber size and muscle mass due, in part, to constitutive activation of the Akt pathway. Their muscles were fibrotic and exhibited impaired membrane integrity accompanied by an apparent compensatory activation of the dystrophin-glycoprotein complex along with elevated expression of proteins involved in muscle repair function. Ptrf deletion also caused decreased mitochondrial function, oxygen consumption, and altered myofiber composition. Thus, in addition to compromised adipocyte-related physiology, the absence of PTRF/cavin-1 in mice caused a unique form of muscular dystrophy with a phenotype similar or identical to that seen in humans lacking this protein. Further understanding of this muscular dystrophy model will provide information relevant to the human situation and guidance for potential therapies.

Entities:  

Mesh:

Substances:

Year:  2017        PMID: 28289716      PMCID: PMC5333963          DOI: 10.1172/jci.insight.91023

Source DB:  PubMed          Journal:  JCI Insight        ISSN: 2379-3708


  65 in total

1.  Lipodystrophy and muscular dystrophy caused by PTRF mutations.

Authors:  W de Haan
Journal:  Clin Genet       Date:  2010-05       Impact factor: 4.438

Review 2.  Fiber types in mammalian skeletal muscles.

Authors:  Stefano Schiaffino; Carlo Reggiani
Journal:  Physiol Rev       Date:  2011-10       Impact factor: 37.312

3.  Congenital generalized lipodystrophy, type 4 (CGL4) associated with myopathy due to novel PTRF mutations.

Authors:  Savitha Shastry; Mauricio R Delgado; Eray Dirik; Mehmet Turkmen; Anil K Agarwal; Abhimanyu Garg
Journal:  Am J Med Genet A       Date:  2010-09       Impact factor: 2.802

4.  Muscular atrophy of caveolin-3-deficient mice is rescued by myostatin inhibition.

Authors:  Yutaka Ohsawa; Hiroki Hagiwara; Masashi Nakatani; Akihiro Yasue; Keiji Moriyama; Tatsufumi Murakami; Kunihiro Tsuchida; Sumihare Noji; Yoshihide Sunada
Journal:  J Clin Invest       Date:  2006-10-12       Impact factor: 14.808

5.  Congenital generalized lipodystrophy type 4 with muscular dystrophy: clinical and pathological manifestations in early childhood.

Authors:  Nobuyuki Murakami; Yukiko K Hayashi; Yuji Oto; Masahisa Shiraishi; Hisashi Itabashi; Kyoko Kudo; Ichizo Nishino; Ikuya Nonaka; Toshiro Nagai
Journal:  Neuromuscul Disord       Date:  2013-03-13       Impact factor: 4.296

6.  Membrane repair defects in muscular dystrophy are linked to altered interaction between MG53, caveolin-3, and dysferlin.

Authors:  Chuanxi Cai; Noah Weisleder; Jae-Kyun Ko; Shinji Komazaki; Yoshihide Sunada; Miyuki Nishi; Hiroshi Takeshima; Jianjie Ma
Journal:  J Biol Chem       Date:  2009-04-20       Impact factor: 5.157

7.  Mitsugumin 53 (MG53) facilitates vesicle trafficking in striated muscle to contribute to cell membrane repair.

Authors:  Noah Weisleder; Hiroshi Takeshima; Jianjie Ma
Journal:  Commun Integr Biol       Date:  2009-05

8.  A critical role of cavin (polymerase I and transcript release factor) in caveolae formation and organization.

Authors:  Libin Liu; Paul F Pilch
Journal:  J Biol Chem       Date:  2007-12-03       Impact factor: 5.157

Review 9.  The Pathogenesis and Therapy of Muscular Dystrophies.

Authors:  Simon Guiraud; Annemieke Aartsma-Rus; Natassia M Vieira; Kay E Davies; Gert-Jan B van Ommen; Louis M Kunkel
Journal:  Annu Rev Genomics Hum Genet       Date:  2015-06-04       Impact factor: 8.929

10.  Progressive muscular dystrophy in alpha-sarcoglycan-deficient mice.

Authors:  F Duclos; V Straub; S A Moore; D P Venzke; R F Hrstka; R H Crosbie; M Durbeej; C S Lebakken; A J Ettinger; J van der Meulen; K H Holt; L E Lim; J R Sanes; B L Davidson; J A Faulkner; R Williamson; K P Campbell
Journal:  J Cell Biol       Date:  1998-09-21       Impact factor: 10.539

View more
  5 in total

1.  PV1 in Caveolae Controls Lung Endothelial Permeability.

Authors:  Joshua H Jones; Emily Friedrich; Zhigang Hong; Richard D Minshall; Asrar B Malik
Journal:  Am J Respir Cell Mol Biol       Date:  2020-10       Impact factor: 6.914

2.  Cardiac-Specific Expression of ΔH2-R15 Mini-Dystrophin Normalized All Electrocardiogram Abnormalities and the End-Diastolic Volume in a 23-Month-Old Mouse Model of Duchenne Dilated Cardiomyopathy.

Authors:  Nalinda B Wasala; Jin-Hong Shin; Yi Lai; Yongping Yue; Federica Montanaro; Dongsheng Duan
Journal:  Hum Gene Ther       Date:  2018-03-22       Impact factor: 5.695

3.  Disruption of Growth Hormone Receptor in Adipocytes Improves Insulin Sensitivity and Lifespan in Mice.

Authors:  Edward O List; Darlene E Berryman; Julie Slyby; Silvana Duran-Ortiz; Kevin Funk; Elise S Bisset; Susan E Howlett; John J Kopchick
Journal:  Endocrinology       Date:  2022-10-01       Impact factor: 5.051

4.  Stromal CAVIN1 Controls Prostate Cancer Microenvironment and Metastasis by Modulating Lipid Distribution and Inflammatory Signaling.

Authors:  Jin-Yih Low; W Nathaniel Brennen; Alan K Meeker; Elina Ikonen; Brian W Simons; Marikki Laiho
Journal:  Mol Cancer Res       Date:  2020-06-03       Impact factor: 5.852

5.  In vivo proteomic mapping through GFP-directed proximity-dependent biotin labelling in zebrafish.

Authors:  Zherui Xiong; Harriet P Lo; Kerrie-Ann McMahon; Nick Martel; Alun Jones; Michelle M Hill; Robert G Parton; Thomas E Hall
Journal:  Elife       Date:  2021-02-16       Impact factor: 8.140

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.